Brief: Veracyte sees FY revenue USD 330-340 million
04/05/2023 23:27
May 4 (Reuters) - Veracyte Q1 net income USD -8.1 million. * Q1 gross margin 62% * Q1 revenue USD 82.4 million * Outlook FY revenue growth 11-15% * Outlook FY revenue USD 330-340 million
Recent news on Veracyte
See all newsU.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning
Veracyte gains on data supporting use of prostate cancer test to guide treatment decisions
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina